Combination therapy with chitosan/siRNA nanoplexes targeting PDGF‐D and PDGFR‐β reveals anticancer effect in breast cancer
- 11 December 2022
- journal article
- research article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 25 (2) , e3465
Abstract
Background: Platelet derived growth factors (PDGF)‐D and the expression of its receptor increase in neoplastic progression of cancer. Co‐silencing of growth factor and receptor can be suggested as an important strategy for effective cancer therapy. In the present study, we hypothesized that suppression of PDGF‐D signaling pathway with small interfering RNAs (siRNAs) targeting both PDGF‐D and PDGF receptor (PDGFR)‐β is a promising strategy for anticancer therapy.Methods: Chitosan nanoplexes containing dual and single siRNA were prepared at different weight ratios and controlled by gel retardation assay. Characterization, cellular uptake, gene silencing and invasion studies were performed. The effect of nanoplexes on breast tumor growth, PDGF expression and apoptosis was investigated.Results: We have shown that downregulation of PDGF‐D and PDGFR‐β with chitosan/siRNA nanoplex formulations reduced proliferation and invasion in breast cancer cells. In the in vivo breast tumor model, it was determined that the intratumoral administration of chitosan/siPDGF‐D/siPDGFR‐β nanoplexes markedly decreased the tumor volume and PDGF‐D and PDGFR‐β mRNA and protein expression levels and increased apoptosis.Conclusions: According to the results obtained, we evaluated the effect of PDGF‐D and PDGFR‐β on breast tumor development and showed that RNAi‐mediated inhibition of this pathway formulated with chitosan nanoplexes can be considered as a new breast cancer therapy strategy.Keywords
This publication has 31 references indexed in Scilit:
- Investigation of the Therapeutic Efficacy of Codelivery of psiRNA–Vascular Endothelial Growth Factor and pIL-4 into Chitosan Nanoparticles in the Breast Tumor ModelJournal of Pharmaceutical Sciences, 2014
- Delivery materials for siRNA therapeuticsNature Materials, 2013
- Chitosan-based nanoparticles for in vivo delivery of interfering agents including siRNACurrent Opinion in Colloid & Interface Science, 2013
- Emerging roles of PDGF-D in EMT progression during tumorigenesisCancer Treatment Reviews, 2013
- siRNA delivery with chitosan nanoparticles: Molecular properties favoring efficient gene silencingJournal of Controlled Release, 2012
- Action and Reaction: The Biological Response to siRNA and Its Delivery VehiclesMolecular Therapy, 2012
- Local Delivery of Chitosan/VEGF siRNA Nanoplexes Reduces Angiogenesis and Growth of Breast Cancer In VivoNucleic Acid Therapeutics, 2012
- Emerging roles of PDGF-D signaling pathway in tumor development and progressionBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2010
- Functions of Paracrine PDGF Signaling in the Proangiogenic Tumor Stroma Revealed by Pharmacological TargetingPLOS Medicine, 2008
- Expression of endothelial PDGF receptors α and β in breast cancer: Up-regulation of endothelial PDGF receptor βOncology Reports, 2007